SCHEMBL24256782

SCHEMBL24256782

COC1OC(COCc2ccccc2)C(OCc2ccccc2)C(OCc2ccccc2)C1N

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SSTR1 P30872 1/20 0.61
▸ SSTR2 P30874 1/20 0.61
▸ SSTR4 P31391 1/20 0.61
▸ SSTR3 P32745 1/20 0.61
▸ SSTR5 P35346 1/20 0.61
▸ GJB2 P29033 2/20 0.59
▸ NT5E P21589 1/20 0.48
▸ HTR1A P08908 1/20 0.47
▸ PTPN1 P18031 8/20 0.47
▸ PTPN2 P17706 3/20 0.47
▸ CA1 P00915 1/20 0.46
▸ CA2 P00918 1/20 0.46
▸ CA9 Q16790 1/20 0.46
▸ CDC25B P30305 6/20 0.46
▸ BCHE P06276 1/20 0.45
▸ PTPN6 P29350 2/20 0.44
▸ PTPN11 Q06124 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23705276 1.00 SSTR1 (0.61) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL25880600 1.00 SSTR1 (0.61) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL25871572 1.00 SSTR1 (0.61) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL23705151 1.00 SSTR1 (0.61) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL6805981 0.91 GJB2 (0.53) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL15514243 0.91 GJB2 (0.53) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL15541898 0.91 GJB2 (0.53) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL5555711 0.91 GJB2 (0.53) SSTR1SSTR2SSTR4SSTR3SSTR5
Hydrochloric Acid SCHEMBL29410631 0.90 GJB2 (0.53) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL3752668 0.89 SSTR1 (0.70) SSTR1SSTR2SSTR4SSTR3SSTR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022035997-A1 IN VIVO ASSEMBLY OF ASGPR BINDING THERAPEUTICS AVILAR THERAPEUTICS, INC. (US) 2022-02-17 — — WO disclosed
Send feedback